Technology News and Research

RSS

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Adaptimmune today announced that it has been awarded a grant of £2.1 million from the Biomedical Catalyst Fund, managed by the UK’s innovation agency the Technology Strategy Board and the Medical Research Council. The prestigious award will expedite the development of Adaptimmune’s second engineered T cell therapy programme into the clinic in triple negative breast cancer.

26 Mar 2014

Cogstate's cognition test to play key role in A4 trial for Alzheimer’s disease

Cognition testing technology developed by Cogstate will be used to track the neurological health of elderly people involved in the multinational Phase III clinical trial of a promising new Alzheimer’s disease (AD) drug.

26 Mar 2014

Studying brain network changes in stroke patients possible with functional network connection models

Studies have shown that functional network connection models can be used to study brain network changes in patients with schizophrenia. A research team from Huazhong University of Science and Technology in China inferred that these models could also be used to explore functional network connectivity changes in stroke patients.

26 Mar 2014

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

Roy Curtiss III, a scientist at the Biodesign Institute at Arizona State University, has been selected as the 2014 recipient of the Lifetime Achievement Award from the American Society for Microbiology.

26 Mar 2014

New mathematical model predicts blood glucose levels with more than 90% accuracy

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels -- plenty of time to take preventative action.

26 Mar 2014

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Axonics Modulation Technologies, Inc., a developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million Series A preferred stock financing.

25 Mar 2014

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.

From Tecan 25 Mar 2014

North Coast Medical announces acquisition of ActivaTek

North Coast Medical, Inc., a manufacturer and global supplier of physical rehabilitation medical products, today announced the acquisition of Salt Lake City, Utah-based ActivaTek, Inc., a privately held manufacturer of transdermal iontophoretic devices.

25 Mar 2014

BioRestorative Therapies, Rohto sign Research and Development Agreement

BioRestorative Therapies, Inc., a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement with Rohto Pharmaceutical Company, Ltd. Under the Agreement, BRT has been engaged to provide stem cell research and development services.

25 Mar 2014

LGL Group's total revenues for Q4 2013 decrease 6.6% to $5.7 million

The LGL Group, Inc., announced results for the full year and quarter ended December 31, 2013.

25 Mar 2014

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.

25 Mar 2014

PatientPoint signs distribution agreement with HealthTronics IT Solutions for urology technology

PatientPoint announced today that they have entered into a distribution agreement with HealthTronics IT Solutions to deliver population health management solutions within urology to drive improved adherence and compliance.

25 Mar 2014

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

ETG or Endogenous Tissue Growth is a new therapeutic category in which surgeons use implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside without the use of stem cells or animal-derived products.

25 Mar 2014

Protein known to promote cancer appears to give blood vessels strength and shape, researchers report

A protein known to promote cancer appears to give the blood vessels strength and shape, researchers report. When yes-associated protein, or YAP, is deleted from vascular smooth muscle cells during development, the protein makes thin-walled blood vessels that over-dilate in response to the usual pressure of blood flow, said Dr. Jiliang Zhou, vascular biologist at the Medical College of Georgia at Georgia Regents University.

25 Mar 2014

tPA can improve chances of recovering from stroke

When the clock starts ticking after the onset of stroke symptoms, access to a neurologist is crucial. Quickly diagnosing a stroke allows for the administration of lifesaving tPA (tissue plasminogen activator) in patients who quality for this treatment.

25 Mar 2014

WHO report confirms air pollution as world's largest single environmental health risk

In new estimates released today, WHO reports that in 2012 around 7 million people died - one in eight of total global deaths - as a result of air pollution exposure. This finding more than doubles previous estimates and confirms that air pollution is now the world's largest single environmental health risk. Reducing air pollution could save millions of lives.

25 Mar 2014

Bielefeld neuroscientists present a new bodily illusion

To induce an illusory perception of the material properties of the hand, a group of neuroscientists from Bielefeld University, the Max-Planck Institute for Biological Cybernetics (Germany), and the University of Milano-Bicocca (Italy) asked volunteers to sit with their hands lying on a table in front of them.

25 Mar 2014

Researchers exploit plasmonic nanoparticles to kill tumour cells

If you put your hand over a switched-on torch in the dark, it appears to glow red. This is because long-wavelength red light beams penetrate human tissue more effectively than short-wavelength blue light.

25 Mar 2014

Study suggests that self-administration of influenza vaccine may be feasible with microneedle patch

There are many reasons some people may not get a flu shot, but would they be more likely to do so if there was a simple device that could be mailed directly to them, was easy enough to use by themselves, and provided at least the same level of protection as a traditional flu shot without the pain of a needle jab? A recent NIBIB-funded study, published online February 2014 in the journal Vaccine, suggests the answer is yes.

25 Mar 2014

New technology gives tool to examine membrane proteins in natural environment of human cell

Scientists have a better way to study human proteins - large molecules that are part of every cell in the body - thanks to a new technology developed by University of Toronto researchers.

25 Mar 2014

Technology News and Research

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Cogstate's cognition test to play key role in A4 trial for Alzheimer’s disease

Studying brain network changes in stroke patients possible with functional network connection models

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

New mathematical model predicts blood glucose levels with more than 90% accuracy

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

North Coast Medical announces acquisition of ActivaTek

BioRestorative Therapies, Rohto sign Research and Development Agreement

LGL Group's total revenues for Q4 2013 decrease 6.6% to $5.7 million

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

PatientPoint signs distribution agreement with HealthTronics IT Solutions for urology technology

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

Protein known to promote cancer appears to give blood vessels strength and shape, researchers report

tPA can improve chances of recovering from stroke

WHO report confirms air pollution as world's largest single environmental health risk

Bielefeld neuroscientists present a new bodily illusion

Researchers exploit plasmonic nanoparticles to kill tumour cells

Study suggests that self-administration of influenza vaccine may be feasible with microneedle patch

New technology gives tool to examine membrane proteins in natural environment of human cell

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News